Seattle Genetics plans stock sale worth $106.6 million based on Monday’s closeBOTHELL, Wash. —Biotechnology company Seattle Genetics Inc. said on Monday it will sell 9 million shares of common stock, with a 30-day option for underwriters to buy another 1.35 million shares. |